Characterization of the deamidase enzyme responsible for the metabolism of the anti-cancer peptide: H-Arg-d-Trp-NmePhe-d-Trp-Leu-Met-NH2
- 1 August 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (5) , 585-590
- https://doi.org/10.1016/0006-2952(95)00191-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]-substance P (6–11) by a small cell lung cancer cell line (H69)Biochemical Pharmacology, 1995
- Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cellsBiochemical Journal, 1994
- Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8-substance P (6–11) characterized by high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1994
- Recognition of C-terminal amide groups by (serine) carboxypeptidase Y investigated by site-directed mutagenesis.Journal of Biological Chemistry, 1994
- A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein".Journal of Biological Chemistry, 1990
- Multiple neuropeptides mobilise calcium in small cell lung cancer: Effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensinBiochemical and Biophysical Research Communications, 1989
- Peptides and growth factors in small cell lung cancer: production, binding sites, and growth effectsZeitschrift für Krebsforschung und Klinische Onkologie, 1988
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977